India's regulatory and policy reforms are crucial for the future of pharmaceutical R&D, streamlining approval processes and strengthening IP protections. Despite significant transformation, challenges like inadequate drug regulation capacity and high compliance costs hinder growth. The report suggests promoting India as a hub for pharmaceutical research and development.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.